Can maternal urinary and serum carbohydrate antigen 19-9 concentrations be utilized in the diagnosis of fetal hydronephrosis?
| dc.contributor.author | Murat AKBAŞ | |
| dc.contributor.author | Faik Mümtaz KOYUNCU | |
| dc.contributor.author | Burcu ARTYNC ULKUMEN | |
| dc.contributor.author | Fatma TANELİ | |
| dc.contributor.author | Habib ÖZDEMİR | |
| dc.date.accessioned | 2024-07-24T09:10:47Z | |
| dc.date.available | 2024-07-24T09:10:47Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Objective: Fetal hydronephrosis (FH) is the most common fetal renal pathology encountered in daily obstetric practice. Urinary and serum carbohydrate antigen 19-9 (CA 19-9) concentrations are elevated in obstructive renal pathologies. Our aim was to assess maternal urinary and serum CA 19-9 concentrations in pregnancies with FH and compare results with controls.Material and Methods: Twenty pregnancies with severe FH, 20 pregnancies with mild-moderate FH, and 20 healthy singleton pregnancies were included in this descriptive, case-control study. The diagnosis and classification of FH was based on the anterioposterior diameter of fetal renal pelvis. Maternal urinary and serum CA 19-9 concentrations were measured and compared between groups.Results: Severe FH cases had significantly higher maternal urinary CA 19-9 concentrations compared to controls (median: 75 vs 24 U/mL; respectively; p=0.014). Concentrations of CA 19-9 did not differ between the mild-moderate FH group and control group. No statistically significant difference was found between the groups with respect to maternal serum CA 19-9 concentrations.Conclusion: Our results show that maternal urinary CA 19-9 concentration is significantly higher in pregnancies with severe FH. However, no difference was detected in serum CA 19-9 concentrations between pregnancies with severe FH, mild-moderate FH and controls. If the mechanisms of transplacental passage and maternal urinary excretion are clarified, maternal urinary CA 19-9 may be a potential marker for indicating fetal kidney damage. (J Turk Ger Gynecol Assoc 2020; 21: 41-5) | |
| dc.identifier.DOI-ID | 10.4274/jtgga.galenos.2019.2019.0101 | |
| dc.identifier.issn | 1309-0399 | |
| dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/23193 | |
| dc.language.iso | eng | |
| dc.title | Can maternal urinary and serum carbohydrate antigen 19-9 concentrations be utilized in the diagnosis of fetal hydronephrosis? | |
| dc.type | Araştırma Makalesi |